A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SM / streptomycin

[Related PubMed/MEDLINE]
Total Number of Papers: 403
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SM  (>> Co-occurring Abbreviation)
Long Form:   streptomycin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Accuracy of a reverse dot blot hybridization assay for simultaneous detection of the resistance of four anti-tuberculosis drugs in Mycobacterium tuberculosis isolated from China. DST, EMB, RDBH, RIF
2020 Chronotoxicity of Streptomycin-Induced Renal Injury in Mice. ---
2020 The role of desmin alterations in mechanical electrical feedback in heart failure. HF, MEF, VA
2019 Antibiotic susceptibility of plant-derived lactic acid bacteria conferring health benefits to human. GM, KM, LAB, LSM, MH, MIC
2019 Drug resistance profile of Mycobacterium tuberculosis isolates from patients referred to tuberculosis reference laboratory in Kosovo. EMB, MDR-TB, RIF, TB
2019 Evaluation of Whole-Genome Sequence Method to Diagnose Resistance of 13 Anti-tuberculosis Drugs and Characterize Resistance Genes in Clinical Multi-Drug Resistance Mycobacterium tuberculosis Isolates From China. CLO, EMB, LFX, MDR-TB, MFX, PAS, Pto, PZA, RIF, SLIDs, WGS
2019 Mutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin in M. tuberculosis. PZA
2019 Mycobacterium tuberculosis DosR regulon gene Rv2004c contributes to streptomycin resistance and intracellular survival. M. smegmatis, TB
2019 Primary drug resistance of mycobacterium tuberculosis in Shandong, China, 2004-2018. DR-TB, MR-TB, RFP
10  2019 Rapid direct drug susceptibility testing of Mycobacterium tuberculosis based on culture droplet digital polymerase chain reaction. ddPCR, qPCR, RMP
11  2018 A Chip for Detecting Tuberculosis Drug Resistance Based on Polymerase Chain Reaction (PCR)-Magnetic Bead Molecule Platform. AMK, CPM, EMB, FQs, KM, Mtb, PCR, RFP, SLD
12  2018 Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates. AMK, DST, EMB, FQs, KM, MDR-TB, NGS, PZA, RIF
13  2018 Molecular drug resistance profiles of Mycobacterium tuberculosis from sputum specimens using ion semiconductor sequencing. EMB, FQs, MDR, PZA, RFP
14  2018 Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol. DST, EMB, MDR-TB, MGIT, PCR
15  2018 Prevalence of Pyrazinamide Resistance in Khyber Pakhtunkhwa, Pakistan. AMK, CAP, DST, EMB, KM, KPK, MDR, MOX, Mtb, OFX, PZA, RIF, TB, XDR
16  2018 Synergism of prenylflavonoids from Morus alba root bark against clinical MRSA isolates. AK, CI, DRIs, EM, FICIs, MRSA, MSSA, VA
17  2018 Tag Array gene chip rapid diagnosis anti-tuberculosis drug resistance in pulmonary tuberculosis -a feasibility study. AMK, CPM, DST, FQs, KM, RFP
18  2017 Anti-folates potentiate bactericidal effects of other antimicrobial agents. DHP, PAS, RIF, SMX
19  2017 Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China. AM, APM, Cs, EMB, ETH, MFX, OFX, PAS, RFB, RFP
20  2017 Frequency of rrs and rpsL mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from Iranian patients. DST, MDR, Mtb
21  2017 Mutations in Streptomycin Resistance Genes and Their Relationship to Streptomycin Resistance and Lineage of Mycobacterium tuberculosis Thai Isolates. MDR-TB, SMR, WHO
22  2017 Secretory Proteome Analysis of Streptomycin-Resistant Mycobacterium tuberculosis Clinical Isolates. ---
23  2017 [Diagnostic value of different detection methods for Mycobacterium tuberculosis in bronchoalveolar lavage fluid from pulmonary tuberculosis patients]. BALF, PCR, RDB, RFP
24  2017 [Evaluation of a high-intensity fluorescent fluorophage method for diagnosis of drug-resistance in tuberculosis]. RIF
25  2017 [Genotyping and drug susceptibility of Mycobacterium tuberculosis isolated in Changping district in Beijing, 2011-2015]. AMK, EMB, OFX, RFP, TB
26  2016 Epidemiological Trends of Drug-Resistant Tuberculosis in China From 2007 to 2014: A Retrospective Study. CI, DR-TB, EMB, MDR-TB, OR, RFP, RMR
27  2016 First-Line Anti-Tubercular Drug Resistance of Mycobacterium tuberculosis in IRAN: A Systematic Review. EMB, MDR, RIF, TB
28  2016 Isoniazid resistance among rifampicin-susceptible Mycobacterium tuberculosis isolates from tuberculosis patients. EMB, Mtb, RIF
29  2016 Outcomes of Category I and II regimens in mono- and polyresistant tuberculosis cases in the Philippines. EMB, TB
30  2016 PARP-1-modulated AIF translocation is involved in streptomycin-induced cochlear hair cell death. AIF
31  2016 Population-Based Drug Resistance Surveillance of Multidrug-Resistant Tuberculosis in Taiwan, 2007-2014. AM, CAP, DST, EA, EMB, GAT, KM, LVX, MDR-TB, MOX, OFX, PAS, PZA, RIF
32  2016 [CLINICAL EFFECTS OF INTRAVENOUSLY ADMINISTERED LEVOFLOXACIN IN PATIENTS WITH PULMONARY TUBERCULOSIS: A RETROSPECTIVE STUDY]. HIV, LVFX
33  2016 [EXTERNAL QUALITY ASSESSMENT OF ANTI-TUBERCULOSIS DRUG SUSCEPTIBILITY TESTING FOR DIAGNOSING EXTENSIVELY DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS]. DST, EB, EQA, KM, LVFX, MDR-TB, RFP, XDR-TB
34  2015 Antibacterial susceptibility of enterobacteriaceae isolated from raw horsemeat isolated for human consumption (basashi). CAZ, CTRX, FOM, KM, MIC, NA, OFLX, TC
35  2015 Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study. CSF, EMB, MDR, RIF, TBM
36  2015 Differential expression of efflux pump genes of Mycobacterium tuberculosis in response to varied subinhibitory concentrations of antituberculosis agents. CFU, EMB, MIC, qRT-PCR, RIF
37  2015 Drug-resistant tuberculosis can be predicted by Mycobacterial interspersed repetitive unit locus. EMB, OR, PZA, RFP
38  2015 Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan. BU, CAM, LVFX, RFP
39  2015 Isolation of multiple drug-resistant enteric bacteria from feces of wild Western Lowland Gorilla (Gorilla gorilla gorilla) in Gabon. CEZ, CL, CP, CPFX, CTX, GM, KM, NA, TC, TMP
40  2015 Multi-color quantum dot-based fluorescence immunoassay array for simultaneous visual detection of multiple antibiotic residues in milk. Abs, PCG, QD, TC
41  2015 Mycobacterium tuberculosis resistance pattern against first-line drugs in patients from urban area. EMB, MDR, RIF, TB
42  2015 Nationwide survey of anti-tuberculosis drug resistance in Japan. EMB, LVX, RMP
43  2015 Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis. DR-TB, DST, EMB, MDR-TB, RMP, SSA, WHO
44  2015 [CLINICAL EFFECTS OF TREATMENT FOR MYCOBACTERIUM TUBERCULOSIS INFECTION IN PATIENTS AT A SPECIALIZED HOSPITAL IN 2011]. EB, MDR-TB, PZA, RFP
45  2015 [EVALUATION STANDARD OF EXTERNAL QUALITY ASSESSMENT PROGRAMME FOR DRUG SUSCEPTIBILITY TESTING OF MYCOBACTERIUM TUBERCULOSIS IN JAPANESE LABORATORIES: PROFICIENCY TESTING IN 2004-2010]. DST, EB, EQA, RFP
46  2014 A chloroplast-targeted DnaJ protein contributes to maintenance of photosystem II under chilling stress. PSII
47  2014 Comparison of the mycobacterium growth indicator tube method and the method of proportion for drug susceptibility testing of mycobacterium tuberculosis. EMB, MDR-TB, MGIT, MOP, NCCLS, RIF
48  2014 Drug resistance of Mycobacterium tuberculosis isolates from tuberculosis lymphadenitis patients in Ethiopia. EMB, MDR-TB, PZA, RMP, TB
49  2014 Evaluation of BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to first-line drugs in China. EMB, LJ, Mtb, NPV, PM, PPV, RIF
50  2014 High level aminoglycoside resistance and distribution of aminoglycoside resistant genes among clinical isolates of Enterococcus species in Chennai, India. AME, GM, HLAR
51  2014 Identifying multidrug resistance in previously treated tuberculosis patients: a mixed-methods study in Cambodia. DST, MDR-TB, TB
52  2014 LeCDJ1, a chloroplast DnaJ protein, facilitates heat tolerance in transgenic tomatoes. ABA, APX, MDA, MV, REC, SOD, WT
53  2014 Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hunan, China. AKM, CAP, EMB, KAN, katG315, OFX, PZA, RIF
54  2014 Pyrosequencing for rapid detection of tuberculosis resistance in clinical isolates and sputum samples from re-treatment pulmonary tuberculosis patients. AMK, DST, EMB, MDR-TB, Mtb, OFL, PTB, RIF
55  2014 Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China. EMB, KAN, OFLX, RIF
56  2014 Risk factors and drug-resistance patterns among pulmonary tuberculosis patients in northern Karnataka region, India. anti-TB, DST, EMB, LJ, PZA, RIF, TB, ZN
57  2014 Streptomycin inhibits electrophysiological changes induced by stretching of chronically infarcted rat hearts. LAD, MAP, MEF, MI, PVBs, SACs, VT
58  2013 A reduction in anti-tuberculosis drug resistance after the implementation of the national "STOP TB" program in central Taiwan, 2003-2007. EMB, MDR-TB, TB
59  2013 Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam. DST, EMB, FQ, LiPAs, PZA, PZase, RFLPs, RMP, TB
60  2013 Effect of ribosome-targeting antibiotics on streptomycin-resistant Mycobacterium mutants in the rpsL gene. TB
61  2013 Functional role of methylation of G518 of the 16S rRNA 530 loop by GidB in Mycobacterium tuberculosis. ---
62  2013 GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis. ADIH, CIs, ORs, PZA, RMP
63  2013 In vitro antimicrobial susceptibility of Brucella melitensis isolates from sheep in an area endemic for human brucellosis in Turkey. CPFX, GM, PCR, RIF, TC, TMP/SMZ
64  2013 Isoniazid- and streptomycin-resistant miliary tuberculosis complicated by intracranial tuberculoma in a Japanese infant. TB
65  2013 Low abundance of respiratory nitrate reductase is essential for Escherichia coli in resistance to aminoglycoside and cephalosporin. CAZ, GEN, NA, Nar, TET
66  2013 Molecular characterisation of drug resistance in Mycobacterium tuberculosis isolates from North India. RMP, TB
67  2013 Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan, 2007-2011. DST, EMB, EQA, RMP
68  2013 [Outbreak of extensively drug-resistant pulmonary tuberculosis in a hemodialysis facility]. EB, KM, LTBI, LVFX, RFP, XDR-TB
69  2013 [Tuberculosis annual report 2010 - (8) treatment of tuberculosis-1]. EB, PZA, RFP, TB
70  2012 Antimycobacterial and synergistic effects of 18beta-glycyrrhetinic acid or glycyrrhetinic acid-30-piperazine in combination with isoniazid, rifampicin or streptomycin against Mycobacterium bovis. 18ssGA, FICI, FICI 0.114-0.313, MICs, RIF
71  2012 Association of streptomycin resistance mutations with level of drug resistance and Mycobacterium tuberculosis genotypes. MIC, RMP
72  2012 Derivatives of 3-isoxazolecarboxylic acid esters: a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis. anti-TB, Mtb, NRP-TB, R-TB, RMP
73  2012 First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia. DST, EMB, MDR, PZA, RMP, TB
74  2012 Molecular typing of Mycobacterium tuberculosis isolates circulating in Henan, central China. EMB, INH, MDR, MT, RFP
75  2012 Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients. ADR, HIV, MDH, OFX, TB
76  2012 Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period. CAM, EB, MAC, MIC, RFP
77  2012 The beginning of the rpoB gene in addition to the rifampin resistance determination region might be needed for identifying rifampin/rifabutin cross-resistance in multidrug-resistant Mycobacterium tuberculosis isolates from Southern China. EMB, RFB, RIF
78  2011 A case of isoniazid-resistant miliary tuberculosis in which tuberculous meningitis paradoxically developed despite systemic improvement. EB, LVFX, PZA, RFP
79  2011 Drug resistance among Mycobacterium tuberculosis isolates from private clinics and a dots center in Delhi, India. EMB, MDR, RIF
80  2011 Drug resistance patterns in pulmonary tuberculosis. DR-TB, DST, EMB, LJ, Mtb, PTB, PZA, RIF, ZN
81  2011 High-resolution melting facilitates mutation screening of rpsL gene associated with streptomycin resistance in Mycobacterium tuberculosis. HRM, M. tuberculosis, XDR-TB
82  2011 Mutations in gidB confer low-level streptomycin resistance in Mycobacterium tuberculosis. ---
83  2011 Mycobacterium tuberculosis complex drug resistance pattern and identification of species causing tuberculosis in the West and Centre regions of Cameroon. EMB, MDR, MTBC, RIF, TB
84  2011 Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of beta-glucuronidase activity in intestinal lumen. beta-GLU, CES, SN-38G, UGT
85  2011 The unsaturation of phosphatidylglycerol in thylakoid membrane alleviates PSII photoinhibition under chilling stress. APX, PG, SOD, WT
86  2011 [Characteristics of Mycobacterium tuberculosis genotype and the relationship between Beijing genotype and drug-resistant phenotypes in Tianjin]. EMB, RFP
87  2011 [Factors related to the occurrence of multi- (extensively-) drug resistant tuberculosis (M/XDR-TB) in our hospital]. EB, PZA, RFP
88  2010 Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso. EMB, HIV, MDR, RMP, TB
89  2010 Declining drug resistance of Mycobacterium tuberculosis isolates from elderly patients in Taiwan, 2000-2008. ADR, EMB, MDR, MDR-TB, Mtb, RIF
90  2010 Molecular characterization of drug-resistant Beijing family isolates of Mycobacterium tuberculosis from Tianjin, China. EMB, M. tuberculosis, RFP, RRDR
91  2010 Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection. AUC, CLA, IQR
92  2010 Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis. MALDI-TOF
93  2010 Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development. anti-TB, Mtb, NRP-TB, R-TB, RMP, SAR
94  2010 Streptomycin induced protein expression analysis in Mycobacterium tuberculosis by two-dimensional gel electrophoresis & mass spectrometry. TB
95  2010 Susceptibility of Mycobacterium tuberculosis to first-line antimycobacterial agents in a Brazilian hospital: assessing the utility of the tetrazolium (MTT) microplate assay. EM, RMP
96  2010 [Resistance rates to major anti-tuberculosis drugs in Mycobacterium tuberculosis strains isolated from seven different regions of Turkey in 2003-2006 period]. EMB, MDR-TB, RMP
97  2009 Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco. EMB
98  2009 Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin. AMK, KM
99  2009 Effect of age on susceptibility to Salmonella Typhimurium infection in C57BL/6 mice. S. Typhimurium
100  2009 LC-MS of streptomycin following desalting of a nonvolatile mobile phase and pH gradient. ---